The medication is generally well tolerated in patients with chronic spontaneous urticaria whose symptoms do not respond adequately to H1 antihistamines.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/remibrutinib-csu-shows-sustained-efficacy-1-year-2025a1000w5w?src=rss
Author :
Publish date : 2025-11-19 01:04:00
Copyright for syndicated content belongs to the linked Source.